Image Source: UnsplashHere’s a stock I haven’t thought about in a long time: Covid-mega-beneficiary Moderna (MRNA), which seems to have a rock-solid price sealing at about $118.More By This Author:Air Products: A Compelling Short OpportunityThis Is How AI Destroys A CompanyUtilities On Deck